Improved contrast in multispectral phase images derived from magnetic resonance exams of multiple sclerosis patients

J R Mitchell1, B K Rutt

  • 1Department of Radiology, Seaman Family MR Research Center, University of Calgary, Alberta, Canada. rmitch@irus.rri.on.ca

Medical Physics
|May 30, 2002
PubMed

Insights

A new spectral phase (SP) imaging method enhances MRI data for Multiple Sclerosis (MS) patients. This technique improves tissue contrast, aiding in the analysis of MS lesions and disease activity.

Area of Science:

  • Medical Imaging
  • Neuroscience
  • Radiology

Background:

  • Multiple Sclerosis (MS) diagnosis and monitoring rely heavily on Magnetic Resonance Imaging (MRI).
  • Current MRI techniques face challenges in differentiating MS lesions from normal-appearing tissues.
  • Improving contrast in MRI can enhance the detection and quantification of MS pathology.

Purpose of the Study:

  • To develop and evaluate a novel method for extracting spectral phase (SP) data from multispectral MR exams of MS patients.
  • To assess the image quality and diagnostic utility of SP images compared to conventional MRI sequences.
  • To determine if SP images offer improved contrast for MS lesion analysis.

Main Methods:

  • A new technique was developed to generate spectral phase (SP) images from multispectral MR exams.
  • SP images were created relative to reference tissues like cerebrospinal fluid (CSF), normal-appearing white matter (NAWM), gray matter (GM), and temporalis muscle (MUS).
  • Image quality and contrast were evaluated by measuring the signal-difference-to-noise ratio (dSNR) between tissues and MS lesions in SP images versus original and processed MR images.

Main Results:

  • The developed SP imaging method successfully produced images with suppressed reference tissue signal while maintaining high spatial resolution.
  • SP images demonstrated significantly improved contrast between various tissues (CSF, NAWM, GM) and MS lesions compared to original MR, filtered MR, and principal component (PC) images.
  • Specific contrast improvements included: CSF/NAWM (19.5 to 56), CSF/GM (15 to 36), GM/NAWM (8 to 14), MS lesions/CSF (16 to 35), and MS lesions/NAWM (24 to 47).

Conclusions:

  • The novel spectral phase (SP) imaging technique offers superior tissue contrast in MRI for Multiple Sclerosis patients.
  • Enhanced contrast in SP images may significantly aid in the quantification and analysis of MS lesion activity.
  • This method holds promise for improving diagnostic accuracy and monitoring disease progression in MS.